Andromeda
Backed by Main Sequence · andromedarobotics.ai ↗
- Founded
- 2022
- Head office
- Melbourne, Australia
Andromeda builds personalised robot companions for aged care and assisted living. The robots are used by care teams to give residents company and connection, with the aim of improving their wellbeing.
Why it matters in Australia: Australian fund Main Sequence has backed Andromeda since 2026.
Backed by
- Main Sequence first invested 2026 Main Sequence profile ↗
Similar companies
Accretion Bio
To cure disease, you first have to see it. We watch single molecules move inside living neurons in real time - revealing how brain disease begins, and how to stop it.
Everlab
Marc, Sam, Anshul and Steven are on a mission to help people live longer, healthier lives.
9 roles in Australia
Auggie
Auggie is the AI patient retention platform that turns dormant dental patient lists into recovered revenue.
Currus Biologics
Developing the next generation of CAR-T cell therapies to treat solid cancers.
indi
One connected system for child development care
Minikai
Your AI ally in disability and aged care.
The summary above was written with AI from the company's own site and its backers' listings, and checked by an editor. Backers, years and rounds are as each fund lists them. Founded year, head office, founders and offices are as robozaps.com and au.linkedin.com state them. Open roles are read daily from the funds' jobs boards.